Ignite Creation Date:
2024-05-06 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 2:31 PM
Study NCT ID:
NCT05360238
Status:
TERMINATED
Last Update Posted:
2023-12-20
First Post:
2022-04-14
Brief Title:
Study to Assess Safety Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL
Sponsor:
Mustang Bio
Organization:
Mustang Bio
Organization Data
Organization:
Mustang Bio
Class:
INDUSTRY
Study ID:
MB106-CD20-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mustang Bio
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |